GE Healthcare Joins Personalized Medicine Fray, Seeks Drug Firm Alliances
This article was originally published in The Pink Sheet Daily
Executive Summary
Amersham protein separation technology is key to GE Healthcare's personalized medicine venture, likely to lead to drug R&D deals in diagnostic/therapy combinations. GE Healthcare projects $16 bil. in 2005 revenue.